DRKS00020506已完成不适用
The intestinal microbiome as a predictive biomarker for efficacy and side effects of CAR-T cell therapy in blood cancers - MiCART
Deutsches Krebsforschungszentrum (DKFZ)0 个研究点目标入组 66 人开始时间: 2020年1月20日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 66
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •lymphoma / leukemia patients with medically indicated CD19 CAR-T cell therapy
- •-persons who have understood the informed consent and signed the written consent form
排除标准
- •- Refusal by the patient
- •- Lack of ability to consent
研究者
相似试验
招募中
不适用
Predictive Value of Human Microbiome and Serological Markers for Clinical Outcome of Cerebral HemorrhageHemorrhagic StrokeAcuteOutcomesMetabolitesGut MicrobiotaNCT05551923Nanfang Hospital, Southern Medical University300
招募中
不适用
Predictive biomarkers and the role of the microbiome determining response to antiinflammatory treatment in Inflammatory Bowel Disease (Crohn's disease and ulcerative colitis)inflammatory Bowel Disease10017969Crohn's diseaseulcerative colitisNL-OMON50413Academisch Medisch Centrum2,240
招募中
不适用
Predicting the impact of the gut microbiome on immunosuppressive drug metabolism in kidney transplant patientsKidney TransplantationDRKS00023398niversitätsklinikum Heidelberg130
招募中
不适用
The analysis of the microbiota as biomarkers of response to anticancer drugs in metastatic solid cancersJPRN-UMIN000030778Department of Internal Medicine, Division of Medical Oncology, Showa University School of Medicine.60
暂停
不适用
Influence of the intestinal microbiome on the risk of spontaneous bacterial peritonitis in patients with decompensated liver cirrhosisK65K74.6Other and unspecified cirrhosis of liverPeritonitisDRKS00026834Klinik und Poliklinik für Innere Medizin II Klinikum rechts der Isar der TU München120